Keywords
L6 myoblasts
Column chromatography
Nile red staining
Submitted : 2024-02-28
Accepted : 2024-03-14
Published : 2024-03-29
Abstract
Syzygium jambolanum is a promising natural treatment for diabetes. The potential benefits of S jambolanum for diabetes include lowering blood sugar levels, increasing insulin sensitivity, protecting pancreatic beta cells, and slowing the absorption of glucose into the bloodstream. The anti-diabetic activity of the crude extract of S jambolanum was evaluated in L6 myotubes and the lipid deposition in tissue was measured using Nile red Staining. Nile red staining confirmed that a considerable quantity of lipids had been deposited in the tissue treated with a crude extract of S jambolanum, comparable to the quantity of lipids deposited with a standard drug known as Rosiglitazone. This study analyzed the anti-diabetic activity of a crude extract of S jambolanum to understand its potential as a feedstock for extracting bioactive constituents to screen for bioactive molecules in the treatment of diabetes.
References
Cheuka PM, Mayoka G, Mutai P, et al., 2016, The Role of Natural Products in Drug Discovery and Development Against Neglected Tropical Diseases. Molecules, 22(1): 58.
Bernardini S, Tiezzi A, Laghezza Masci V, et al., 2018, Natural Products for Human Health: An Historical Overview of The Drug Discovery Approaches. Natural product research, 32(16): 1926–1950.
World Health Organization, 2009, The Use of Herbal Medicines in Primary Health Care, WHO Regional Office for South-East Asia. Report of the Regional Meeting, Myanmar, 2009: 10–12.
Cordell GA, 2011. Sustainable Medicines and Global Health Care. Planta medica, 77(11): 1129–1138.
Baliga MS, Fernandes S, Thilakchand KR, et al., 2013, Scientific Validation of The Antidiabetic Effects of Syzygium Jambolanum DC (Black Plum), A Traditional Medicinal Plant of India. The Journal of Alternative and Complementary Medicine, 19(3): 191–197.
Shrikant Baslingappa S, Nayan Singh JT, Meghatai MP, et al., 2012, Jamun (Syzygium cumini (L.)): A Review of Its Food and Medicinal Uses. Food and Nutrition Sciences, 3(8).
Lim SL, Chai JW, Kuppusamy UR, 2008, Evaluation of Syzygium jambolanum Methanolic Leaf Extract for Insulin- Like Properties. Research Journal of Biological Sciences, 3(9): 1109–1114.
Helmstädter A, 2008, Syzygium cumini (L.) SKEELS (Myrtaceae) against diabetes–125 years of research. Pharmazie-An International Journal of Pharmaceutical Sciences, 63(2): 91–101.
Rao MU, Sreenivasulu M, Chengaiah B, et al., 2010, Herbal Medicines for Diabetes Mellitus: A Review. Int J PharmTech Res, 2(3): 1883–1892.
Al-Rowais NA, 2002, Herbal Medicine in The Treatment of Diabetes Mellitus. Saudi Medical Journal, 23(11): 1327– 1331.
Jarald E, Joshi SB, Jain D, 2008, Diabetes and Herbal Medicines. Iranian Journal of Pharmacology and Therapeutics, 7: 97–106.
Nair KN, (eds) 2017, The Genus Syzygium: Syzygium cumini and Other Underutilized Species. CRC Press, United States.
Nigam V, Nigam R, 2012, Distribution and Medicinal Properties of Syzygium Species. Current Research in Pharmaceutical Sciences, 73–80.
Maiti S, Ali KM, Jana K, et al., 2013, Ameliorating Effect of Mother Tincture of Syzygium jambolanum on Carbohydrate and Lipid Metabolic Disorders in Streptozotocin-Induced Diabetic Rat: Homeopathic Remedy. Journal of Natural Science, Biology, and Medicine, 4(1):68.